TrialClinical therapeutics2007

Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials.

John B Buse et al.PubMed ↗Publisher ↗

No numbers read from the abstract.